Further studies in patients undergoing platinum chemotherapeutics, urinary levels of KIM-1, NGAL, and cystatin C showed a statistically significant early increase after treatment initiation, preceding sCr rise, in AKI patients [133,167]. Here, HAVCR1 is linked to acute kidney injury.